Related Experiment Video

Updated: Apr 11, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.6K

Intravenous acetaminophen use in pediatrics

Nirav Shastri1

  • 1Associate Professor of Pediatrics (Shastri), University of Missouri-Kansas City School of Medicine, Attending Physician, Emergency Medicine, Children's Mercy Hospital and Clinics, Overland Park, KS.

Pediatric Emergency Care
|June 3, 2015
PubMed

Insights

Intravenous acetaminophen is now available for children in the US. This review covers its use, including how it works, when to use it, and safety measures for pediatric patients.

Area of Science:

  • Pediatric Pharmacology
  • Intravenous Drug Administration

Background:

  • Acetaminophen is a widely used analgesic and antipyretic in pediatric care.
  • Recent FDA approval allows for intravenous administration of acetaminophen in the United States.

Purpose of the Study:

  • To provide a comprehensive review of intravenous acetaminophen in pediatric patients.
  • To detail the pharmacodynamics, indications, contraindications, and precautions associated with its use.

Main Methods:

  • Literature review of existing studies and clinical guidelines.
  • Analysis of pharmacodynamic properties, efficacy, and safety data.
  • Synthesis of information regarding appropriate clinical application.

Main Results:

  • Intravenous acetaminophen offers an alternative route for pediatric pain and fever management.
  • Established guidelines exist for dosing and administration.
  • Specific contraindications and precautions are identified to ensure patient safety.

Conclusions:

  • Intravenous acetaminophen presents a valuable therapeutic option for pediatric patients requiring analgesia or antipyresis.
  • Clinicians should be aware of its pharmacokinetic and pharmacodynamic profile.
  • Careful consideration of indications and contraindications is essential for safe and effective use.

More Related Videos

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.3K
Intravenous Injections in Neonatal Mice05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

62.3K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
388
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
821
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
497
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
352
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
868
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
955